ISSN: 2161-069X
Journal of Gastrointestinal & Digestive System
Open Access
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 2091
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Doxycycline related hepatotoxicity
16th International Conference on Gastroenterology and Digestive Disorders
Saba Vahdat
Islamic Azad University of Medical Sciences, Iran
Posters & Accepted Abstracts: J Gastrointest Dig Syst
DOI:
Abstract
Background and objective: While Tetracyclines are known to cause liver damage, few drug surveillance studies have examined the risk of hepatotoxicity developed by Doxycycline. Doxycycline is commonly used for vaginitis, bronchitis and acne. Therefore the objective of this study is to determine the risk of hepatotoxicity in patients receiving Doxycycline. Participants and Methods: This matched case-control study is using Imam Reza clinic data. The cases were defined as recipients who had at least one diagnosis of hepatotoxicity during a 1.5 year period (from 23 October 2015 till 23 May 2017). The population: 96 cases plus 154 controls in the study. Covariates controlled for in the analysis were age, gender, use of other medications, alcohol or drug use. Main outcome measures: doxycycline exposure prevalence and hepatotoxicity. Results: current or past users of Doxycycline did not have an increased risk of hepatotoxicity. Current use: (OR 1.39, 94%, CI 0.63- 3.74). Past use: (OR 1.71, 94%, CI 0.22- 3.11). Conclusions: The findings of the study suggested no increased risk of hepatotoxicity risk associated with Doxycycline exposure in the study population. Doxycycline could potentially be a safe substitute for tetracycline, when appropriate.Biography
E-mail: sabavf.68@gmail.com
